These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 3920679

  • 1. Verapamil decreases the formation of thromboxane from exogenous 14C-arachidonic acid in human platelets in vitro.
    Dahl ML, Uotila P.
    Prostaglandins Leukot Med; 1985 Feb; 17(2):191-8. PubMed ID: 3920679
    [Abstract] [Full Text] [Related]

  • 2. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP, Maguire MH.
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [Abstract] [Full Text] [Related]

  • 3. Metabolism of arachidonic acid by macaque platelets. Implications for studies on atherosclerosis.
    Beatty CH, Howard CF, Hoskins MK, Herrington PT.
    Atherosclerosis; 1985 Apr; 55(1):1-13. PubMed ID: 3924062
    [Abstract] [Full Text] [Related]

  • 4. Docosahexaenoic acid (C22:6 omega 3) and linoleic acid are anti-aggregatory, and alter arachidonic acid metabolism in human platelets.
    Srivastava KC.
    Prostaglandins Leukot Med; 1985 Mar; 17(3):319-27. PubMed ID: 3158002
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil.
    Han P, Boatwright C, Ardlie NG.
    Thromb Haemost; 1983 Aug 30; 50(2):513-7. PubMed ID: 6314581
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of thromboxane synthetase by OKY-1581 stimulates the formation of PGE2, PGF2 alpha, PGD2 and 6-keto-PGF1 alpha in human platelets.
    Uotila P, Matintalo M.
    Prostaglandins Leukot Med; 1984 Apr 30; 14(1):41-6. PubMed ID: 6427791
    [Abstract] [Full Text] [Related]

  • 8. Effects of dipyridamole, nifedipine, verapamil, hydralazine and propranolol on the formation of prostacyclin and thromboxane in a coupled system of platelets and aorta.
    Srivastava KC.
    Prostaglandins Leukot Med; 1986 Jul 30; 23(1):31-6. PubMed ID: 3090561
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs.
    Maguire MH, Csonka-Khalifah L.
    Biochim Biophys Acta; 1987 Oct 17; 921(3):426-36. PubMed ID: 3117116
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of some saturated and unsaturated fatty acids on in vitro platelet utilization of arachidonic acid.
    Srivastava KC.
    Prostaglandins Med; 1979 Dec 17; 3(6):377-85. PubMed ID: 550161
    [Abstract] [Full Text] [Related]

  • 13. Differential effect of external calcium on the oxygenated metabolism of endogenous and exogenous arachidonic acid in platelets.
    Velardo B, Lagarde M.
    Biochem Biophys Res Commun; 1985 Aug 15; 130(3):1109-14. PubMed ID: 3927915
    [Abstract] [Full Text] [Related]

  • 14. Determination of the formation of thromboxane B2 (TxB2), 12L-hydroxy-5,8,10 heptadecatrienoic acid (HHT) and 12L-hydroxy-5,8,10,14 eicosatrienoic acid (HETE) from arachidonic acid and of the TxB2 :HHT, TxB2 :HETE and (TxB2 +HHT) :HETE ratio in human platelets. Possible use in diagnostic purposes.
    Vincent JE, Zijlstra FJ, van Vliet H.
    Prostaglandins Med; 1980 Aug 15; 5(2):79-84. PubMed ID: 7413847
    [Abstract] [Full Text] [Related]

  • 15. Time-dependent inhibition of the cyclooxygenase pathway by 12-hydroperoxy-5,8,10,14-eicosatetraenoic acid.
    Hashimoto Y, Naito C, Teramoto T, Kato H, Kinoshita M, Kawamura M, Hayashi H, Oka H.
    Biochem Biophys Res Commun; 1985 Jul 31; 130(2):781-5. PubMed ID: 3927909
    [Abstract] [Full Text] [Related]

  • 16. In vitro effect of trichosanic acid, a major component of Trichosanthes japonica on platelet aggregation and arachidonic acid metabolism in human platelets.
    Takenaga M, Hirai A, Terano T, Tamura Y, Kitagawa H, Yoshida S.
    Prostaglandins Leukot Essent Fatty Acids; 1988 Feb 31; 31(2):65-72. PubMed ID: 3357911
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of platelet aggregation and thromboxane production by pinacidil.
    Goodman RP, Little DM, Wright JT.
    Prostaglandins Leukot Med; 1985 Aug 31; 19(2):115-22. PubMed ID: 3931098
    [Abstract] [Full Text] [Related]

  • 18. Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour.
    Parry MJ.
    Br J Clin Pharmacol; 1983 Aug 31; 15 Suppl 1(Suppl 1):23S-29S. PubMed ID: 6401997
    [Abstract] [Full Text] [Related]

  • 19. Effect of furosemide on the in vitro prostaglandin biosynthesis in human platelets.
    Srivastava KC, Awasthi KK.
    Prostaglandins Leukot Med; 1982 Aug 31; 9(2):211-21. PubMed ID: 6812095
    [Abstract] [Full Text] [Related]

  • 20. Transcellular metabolism of arachidonic acid: increased platelet thromboxane generation in the presence of activated polymorphonuclear leukocytes.
    Maugeri N, Evangelista V, Piccardoni P, Dell'Elba G, Celardo A, de Gaetano G, Cerletti C.
    Blood; 1992 Jul 15; 80(2):447-51. PubMed ID: 1627802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.